Bivalirudin renal or liver clearance
WebTraductions en contexte de "fonction rénale ou hépatique est altérée" en français-anglais avec Reverso Context : Étant donné que la clairance du sildénafil est réduite chez les personnes âgées (65 ans et plus) et chez les patients dont la fonction rénale ou hépatique est altérée, il est préférable d'amorcer le traitement à une dose de 25 mg. WebThe disposition of bivalirudin was studied in PTCA patients with mild, moderate and severe renal impairment. The clearance of bivalirudin was reduced approximately 21% in patients with moderate and severe renal impairment and was reduced approximately 70% in dialysis-dependent patients [see Clinical Pharmacology (12.3)].
Bivalirudin renal or liver clearance
Did you know?
WebClearance is reduced approximately 20% in patients with moderate and severe renal impairment and by 80% in dialysis-dependent patients; Bivalirudin is hemodialyzable and approximately 25% is cleared by hemodialysis. Pharmacodynamics. Coagulation times return to baseline approximately 1 hour following cessation of bivalirudin administration. WebJul 1, 2002 · Bivalirudin is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage, with a half-life of 25 min in patients with normal renal function [27]. …
WebApr 30, 2015 · - Advantages and disadvantages of oral anticoagulants - LMW heparin dosing renal insufficiency (adults) - Anticoagulant dose adjustment in liver disease - Possible contraindications to anticoagulation - Standard dosing of DOACs - DOACs PK and drug interactions - Inhibitors and inducers of P-glycoprotein drug efflux - DOAC … WebMar 1, 2024 · The total body clearance of bivalirudin in PTCA patients with normal renal function is 3.4 mL/min/kg. Metabolism. ... Total body clearance was similar for PTCA patients with normal renal function and with mild renal impairment. Clearance was reduced by 21% in patients with moderate and severe renal impairment with a half-life of 34 and …
WebBivalirudin is administered via continuous intravenous infusion, is removed by a combination of proteolytic cleavage by thrombin and renal clearance mechanisms, and … WebBivalirudin is a 20 amino-acids hirudin-analogue with a molecular mass of 2’180 Da and a half-life of ~25 minutes; it is eliminated by proteolysis and for ~20% by renal clearance . Both bind human thrombin reversibly, …
WebBackground: While not approved by the Food and Drug Administration for treatment of heparin-induced thrombocytopenia (HIT), except in patients undergoing percutaneous …
WebTsu LV and Dager WE. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia. Ann Pharmacother 2011; 45(10):1185-92. Runyan CL et al. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia. reagan third termWebClearance is reduced approximately 20% in patients with moderate and severe renal impairment and by 80% in dialysis-dependent patients; Bivalirudin is hemodialyzable … how to take vat away from totalWebAlthough its clearance is largely organ independent (blood proteases), the kidneys provide approximately 20% of its clearance necessitating dose adjustments with moderate renal … how to take vat from a valueWebbivalirudin on liver and kidney function in patients subjected to these procedures. This study compared the effects of bi-valirudin and UFH on liver/renal function in patients … how to take varnish off woodWebMar 22, 2024 · With the available data, anticoagulation with regional citrate significantly prolonged filter life (mean difference, 11.2 h [95% CI 8.2–14.3]) and reduced bleeding … reagan tickleWebFeb 1, 2024 · The elimination half-life of bivalirudin is 20 to 30 min in the presence of normal renal function while with renal dysfunction, half-life … how to take value in pythonWebMay 1, 2024 · Unlike argatroban, bivalirudin is not Food and Drug Administration (FDA)-approved for HIT but is commonly used off-label with a recommended initial dose 0.15 to 0.2 mg/kg/h in patients with normal … reagan those who had the most to lose